Avian Colibacillosis: Etiology, Clinical Signs, and Control of Escherichia coli Infections in Poultry

Introduction

Avian colibacillosis is a complex infectious disease of poultry caused by avian pathogenic Escherichia coli (APEC). It manifests as a range of localized and systemic syndromes, including airsacculitis, pericarditis, perihepatitis, salpingitis, omphalitis, and cellulitis [1, 2, 3]. APEC strains belong to the extraintestinal pathogenic E. coli (ExPEC) pathotype and are characterized by specific virulence determinants that enable colonization of the respiratory tract and systemic dissemination [4, 5, 33]. The disease imposes significant economic losses worldwide due to mortality, reduced growth performance, carcass condemnation, and treatment costs [6, 7, 8]. This article provides a detailed reference on the etiology, clinical signs, pathology, diagnostic approaches, treatment, and control of avian colibacillosis, with emphasis on recent genomic and transcriptomic insights [9, 10, 11, 35].

Etiology and Pathogen Characteristics

APEC strains are Gram-negative, facultative anaerobic bacilli belonging to the Enterobacteriaceae family. They are serotypically diverse, with O1, O2, O18, and O78 being among the most commonly associated with colibacillosis [2, 8, 33]. APEC isolates harbor a distinct set of genes located on large plasmids and pathogenicity islands that encode adhesins, iron acquisition systems, protectins, and toxins [12, 5, 13, 3]. Key virulence factors include type 1 fimbriae (FimH), P-fimbriae (Pap), the aerobactin siderophore system (iuc/iut), the salmochelin system (iroN), and the hemolysin HlyE [13, 14, 28]. The presence of the iroN gene is a strong marker for APEC pathotype and is frequently detected in multidrug-resistant isolates from colibacillosis cases [13, 8]. The ecnAB toxin-antitoxin system modulates capsular sialic acid biosynthesis, thereby influencing virulence and immune evasion [12]. The LsrR quorum-sensing regulator mediates resistance to oxidative stress by interfering with sulfate assimilation, a mechanism that aids bacterial survival within the host phagocytes [15]. Transcriptomic analysis of APEC strains reveals that small RNAs such as RyfA and TimR regulate stress resistance and virulence during host infection [10].

Epidemiology and Transmission

Avian colibacillosis is endemic in commercial poultry operations worldwide. Transmission occurs primarily through the fecal-oral route, inhalation of contaminated dust, and vertical transmission via eggs contaminated on the shell surface or within the reproductive tract [1, 8, 11]. Environmental persistence is facilitated by biofilm formation on litter, surfaces, and equipment [16, 17]. Co-infection with respiratory viruses such as H9N2 avian influenza virus enhances APEC adhesion and invasion of respiratory epithelial cells, exacerbating disease severity [4, 18]. The prevalence of multidrug-resistant (MDR) APEC strains is increasing, with co-existence of extended-spectrum beta-lactamase genes (e.g., blaCTX-M) and colistin resistance genes (e.g., mcr-1) reported in various geographic regions [2, 19, 20]. Fluoroquinolone-resistant APEC strains have been isolated from asymptomatic broilers at slaughter, indicating a reservoir for resistance dissemination [20]. Genomic characterization of APEC from poultry houses provides data for surveillance of antimicrobial resistance (AMR) and virulence markers [9, 5].

Pathogenesis and Virulence Mechanisms

The pathogenesis of avian colibacillosis involves multiple sequential steps: inhalation or ingestion of APEC, adhesion to epithelial surfaces, evasion of host defenses, and systemic dissemination. A schematic representation of the pathogenic cascade is provided in Figure 1.

flowchart TD
    A[Ingestion or inhalation of APEC], > B[Adhesion to respiratory or intestinal epithelium]
    B, > C[Colonization and biofilm formation]
    C, > D[Breach of mucosal barrier]
    D, > E[Entry into bloodstream]
    E, > F[Systemic dissemination]
    F, > G[Infection of internal organs: air sacs, pericardium, liver, spleen, ovary]
    G, > H[Clinical disease: airsacculitis, pericarditis, perihepatitis, salpingitis]
    H, > I[Septicemia and death]

Adhesion is mediated by type 1 and P-like fimbriae, which bind to host glycoprotein receptors; the host range and zoonotic potential of APEC are linked to the specificity of these adhesins [14]. Biofilm formation, regulated by c-di-GMP signaling and the diguanylate cyclase DgcE, contributes to surface persistence and resistance to antimicrobials [21, 16, 17]. The type VI secretion system (T6SS) delivers antimicrobial peptides that target host cells and competing bacteria, enhancing APEC fitness [22]. The type V secretion system eYadA also modulates pathogenicity [32]. Once inside the host, APEC produces toxins such as HlyE variants packaged in extracellular vesicles (EVs) that induce mitochondria-dependent apoptosis in macrophages, facilitating immune evasion [28]. The yolk sac plays a crucial role during embryonic infection, as transcriptomic studies show upregulation of inflammatory and acute-phase response genes in infected embryos [11]. Similarly, transcriptomic profiling of the liver and spleen in infected chickens reveals altered expression of immune and metabolic pathways at different stages of infection [35].

Clinical Signs and Disease Forms

Clinical manifestations of avian colibacillosis depend on the route of infection, age of the bird, and virulence of the APEC strain. The major forms of the disease are summarized in Table 1.

Table 1. Common Clinical Forms of Avian Colibacillosis

| Clinical Form | Affected Population | Key Signs | | :-, | :-, | :-, | | Omphalitis (yolk sac infection) | Chicks (first week) | Swollen abdomen, unabsorbed yolk sac, lethargy, death | | Respiratory form (airsacculitis) | Broilers, layers | Dyspnea, coughing, rales, reduced growth | | Pericarditis and perihepatitis | All ages | Fibrinous exudate on heart and liver, depression, poor feed intake | | Salpingitis and peritonitis | Laying hens | Egg peritonitis, reduced egg production, sudden death | | Colisepticemia | All ages | Acute mortality, cyanosis, swollen joints in chronic cases | | Cellulitis | Broilers | Subcutaneous necrosis, inflammation, skin lesions |

Omphalitis is a classic early manifestation in neonates contaminated through the hatchery environment [1, 11]. The respiratory form often follows viral or mycoplasmal immunosuppression; H9N2 avian influenza virus predisposes birds to secondary APEC infection by damaging mucosal integrity and facilitating bacterial adhesion [4, 18]. Septicemic colibacillosis presents with acute onset of depression, anorexia, and high mortality, while chronic cases may involve joint infections (synovitis) and neurological signs [8, 3].

Pathology and Gross Lesions

Necropsy findings in colibacillosis vary according to the disease form. In septicemic cases, the most characteristic lesions include fibrinous pericarditis (thick, pale exudate covering the heart), perihepatitis (fibrinous layer on the liver surface), and airsacculitis (opaque, thickened air sacs with caseous exudate) [31, 35]. The liver and spleen may be enlarged and congested. In salpingitis, the oviduct is distended with caseous material and yolk debris, often leading to fatal egg peritonitis. Cellulitis presents as diffuse necrotic inflammation of the subcutaneous tissue, typically over the abdomen or thighs. Histopathological examination reveals heterophilic infiltration, fibrin deposition, and necrosis in affected organs [31]. Molecular detection of virulence genes such as iroN, fimH, and papC from lesion samples confirms APEC involvement [13, 31].

Diagnostics

Diagnosis of avian colibacillosis is based on clinical signs, gross pathology, and laboratory isolation of E. coli from lesions or internal organs. For definitive pathotyping, APEC is distinguished from commensal E. coli by detection of specific virulence-associated genes (VAGs) using multiplex PCR or whole genome sequencing (WGS) [9, 5, 3]. Common target genes include iroN, iss, fimH, papC, iutA, hlyF, and ompT. WGS provides high-resolution characterization of serotypes, AMR genes, and phylogenetic relationships [2, 9, 5, 33]. Real-time PCR assays targeting the iroN gene have been developed for rapid detection of APEC in clinical samples [13]. Serotyping using antisera against O antigens remains useful for epidemiological tracking. Antimicrobial susceptibility testing (AST) by broth microdilution or disk diffusion is essential for guiding treatment and monitoring resistance trends [19, 8].

Treatment and Antimicrobial Resistance

Therapeutic management of avian colibacillosis has relied heavily on antibiotics, but increasing levels of resistance limit efficacy. APEC isolates commonly exhibit resistance to tetracyclines, sulfonamides, fluoroquinolones, and third-generation cephalosporins [2, 19, 20]. The emergence of colistin resistance (mcr-1) in conjunction with extended-spectrum beta-lactamases (blaCTX-M) is of particular concern [19]. In one genomic study, an extensively drug-resistant (XDR) APEC strain was characterized, harboring resistance genes to multiple antibiotic classes [2].

Alternative strategies are being intensively investigated. Phage therapy using lytic bacteriophages has shown significant efficacy in reducing APEC loads in experimentally infected chickens, either via drinking water or intramuscular injection [29, 30, 34]. A phage cocktail administered through drinking water suppressed systemic APEC infection and reduced pathology in laying hens [29]. The combination of phages with antibiotics (phage-antibiotic synergism) also disperses biofilms and enhances killing [17]. Antimicrobial peptides derived from the T6SS (e.g., peptide A7) demonstrate potent activity against APEC and methicillin-resistant Staphylococcus aureus (MRSA) [22]. Essential oils and plant extracts, such as Cymbopogon flexuosus essential oil, inhibit biofilm formation and exhibit antibacterial activity against MDR APEC [23, 24]. Deep eutectic solvent-based emulsions containing Piper betle extract prevent biofilm development on stored chicken meat [16]. Probiotic metabolites from Lactobacillus spp. also suppress APEC virulence factors and growth [25]. Monoclonal antibodies targeting the diguanylate cyclase DgcE potentiate gentamicin activity by modulating c-di-GMP signaling [21].

Control and Prevention

Effective control of avian colibacillosis relies on an integrated approach combining biosecurity, management, vaccination, and alternative prophylactics. Strict hygiene in hatcheries, proper egg handling, and control of respiratory viral diseases reduce the incidence of colibacillosis [1, 4]. The use of plant extracts (e.g., Ilex rotunda–Cyperus rotundus herb pair, Balanites aegyptiaca) as feed additives has demonstrated prophylactic effects against APEC infection in chickens, improving organ function biomarkers and modulating lipid metabolism [1, 6, 24]. Myrmecodia sp. extract similarly improved hematological parameters in challenged broilers [6].

Vaccination remains a key goal. Inactivated bacterins and subunit vaccines based on outer membrane proteins (OMPs) or whole cell antigens have shown partial protection [7, 26]. A trivalent inactivated in ovo nanovaccine has been evaluated under commercial hatchery conditions, demonstrating safety, immunogenicity, and compatibility with routine hatchery operations [27]. Epitope-based and peptide-based vaccines designed using machine learning algorithms are in advanced development [7]. Biomimetic vesicles displaying H9 subtype avian influenza virus HA1 protein have been constructed from APEC cells, offering dual protection against colibacillosis and avian influenza [18]. The use of bacterial biomimetic vesicles is a promising platform for multivalent vaccines.

Probiotic metabolites that inhibit APEC adhesion and biofilm formation provide a non-antibiotic means of reducing colonization [25]. Improved ventilation, litter management, and stocking density reduction are critical non-pharmacological interventions.

Zoonotic Considerations: Can You Get E. coli from Chicken?

The question of whether humans can acquire E. coli infection from chickens pertains primarily to foodborne transmission. While APEC is adapted to avian hosts, some strains carry ExPEC-associated virulence genes that may confer potential for extraintestinal infections in humans [14]. Research on P-like fimbrial adhesin specificity indicates that APEC can adhere to human uroepithelial cells under experimental conditions, suggesting a possibility, albeit low, of zoonotic transmission [14]. The majority of E. coli causing human illness are distinct from APEC, but the presence of antimicrobial resistance genes in APEC represents a broader public health concern via horizontal gene transfer [19, 5]. Proper cooking of poultry products and hygienic handling prevent the common foodborne E. coli infections that can be acquired from contaminated chicken.

Conclusion

Avian colibacillosis remains a major challenge in poultry production worldwide. The pathogenicity of APEC is driven by a multifactorial virulence repertoire that includes adhesins, iron acquisition systems, toxins, and quorum-sensing regulators. The emergence of MDR and XDR strains necessitates a shift from reliance on antibiotics toward integrated control measures, including vaccination, phage therapy, probiotics, and plant-based alternatives. Advanced genomic and transcriptomic tools are enhancing our understanding of host-pathogen interactions and facilitating the development of targeted interventions. Continued surveillance of APEC populations in poultry is essential to mitigate the impact of colibacillosis and to address potential zoonotic risks.

References

[1] Liu H, Yang A, Wei X, et al. Preventive effects and underlying mechanisms of Ilex rotunda Thunb.-Cyperus rotundus L. herb pair extract on avian colibacillosis in chickens. Poult Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/42308740/

[2] Ni W, Chen L, Chen H, et al. Genomic and Pathogenic Characterization of an Extensively Drug-Resistant Avian Pathogenic Escherichia coli Strain. Transbound Emerg Dis. 2026. https://pubmed.ncbi.nlm.nih.gov/42147456/

[3] da Silva AL, Luna FS, Nogueira JF, et al. Phenotypical-genetic virulence and resistance in atypical avian pathogenic Escherichia coli. Int Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41922898/

[4] Li Y, Xue Y, Quan Y, et al. Direct interaction between avian pathogenic Escherichia coli and H9N2 avian influenza virus promotes bacterial adhesion during their infections. Microbiol Spectr. 2026. https://pubmed.ncbi.nlm.nih.gov/42294695/

[5] Gaonkar PP, Golden R, Santana-Pereira ALR, et al. Genomic characterization of avian pathogenic Escherichia coli and its potential as a marker organism for antimicrobial resistance. Appl Environ Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42080571/

[6] Lisnanti EF, Lokapirnasari WP, Arif MAA, et al. Comparative effects of Myrmecodia sp. extract and infusion on organ function biomarkers, lipid metabolism, and meat lipid profile in avian pathogenic Escherichia coli-infected broiler chickens: Implications for sustainable poultry production within a One Health framework. Vet World. 2026. https://pubmed.ncbi.nlm.nih.gov/42245456/

[7] Waseem M, Kamran Z, Ali A. Advancing poultry health: A meta-analysis of epitope-based and peptide-based vaccines against Avian Pathogenic E. coli with machine learning insights. PLoS One. 2026. https://pubmed.ncbi.nlm.nih.gov/42201941/

[8] ELTarabili RM, Abo Hashem ME, Ahmed MA, et al. Emergence of multidrug-resistant and virulent Escherichia coli with APEC-associated traits in broiler chickens from Ismailia, Egypt. Sci Rep. 2026. https://pubmed.ncbi.nlm.nih.gov/41965406/

[9] Runcharoon K, Ienes-Lima J, Logue CM. Complete genomes of 21 avian pathogenic Escherichia coli isolated from colibacillosis cases in Georgia poultry. Microbiol Resour Announc. 2026. https://pubmed.ncbi.nlm.nih.gov/42132918/

[10] Anamalé C, Bessaiah H, Ng Kwan Lim E, et al. Orchestrating infection: the impact of RyfA and TimR sRNAs on stress resistance and virulence in avian pathogenic Escherichia coli in chickens. Appl Environ Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42053318/

[11] Wang J, Bajagai YS, Sajid GA, et al. Transcriptomic analysis reveals a crucial role of the yolk sac during Avian Pathogenic Escherichia coli infection in chicken embryos. Poult Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/41887167/

[12] Jing Y, Shen X, Yin D, et al. The ecnAB toxin-antitoxin system modulates avian pathogenic Escherichia coli virulence through regulating the capsular sialic acid biosynthesis pathway. Vet Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42160786/

[13] Keytimu MO, Rahayu U, Wibisono FJ, et al. Detection of the iroN virulence gene in multidrug-resistant Escherichia coli isolated from quails in traditional markets of Surabaya, Indonesia. Vet World. 2026. https://pubmed.ncbi.nlm.nih.gov/42046676/

[14] Akrami F, Jamali H, Houle S, et al. Host range and zoonotic potential linked to P-like fimbrial (PLF) adhesin specificity in avian pathogenic Escherichia coli. PLoS Pathog. 2026. https://pubmed.ncbi.nlm.nih.gov/41941531/

[15] Kong L, Tu C, Song X, et al. Quorum-sensing regulator LsrR modulates resistance to oxidative stress by interfering with sulfate assimilation in avian pathogenic Escherichia coli. J Bacteriol. 2026. https://pubmed.ncbi.nlm.nih.gov/42284197/

[16] Ratchasong K, Saengsawang P, Yusakul G, et al. Deep Eutectic Solvent-Based Emulsion Containing Piper betle L. Extract and Hydroxychavicol Prevent Biofilm Development and Surface Adhesion of Avian Pathogenic Escherichia coli on Stored Chicken Meat. Antibiotics (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/42041291/

[17] Bhutada P, Joshi N, Saroj SD, et al. Dynamics of multidrug-resistant avian pathogenic E. coli biofilm formation on various surfaces and its dispersion with phage antibiotic synergism. BMC Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/41957569/

[18] Li Y, Quan Y, Quan K, et al. Construction and immunogenicity evaluation of avian Escherichia coli-derived bacterial biomimetic vesicles displaying H9 subtype avian influenza virus HA1 protein. Vet Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42061219/

[19] Yang B, Xing G, Ma W, et al. Co-existence of blaCTX-M and mcr-1 in avian pathogenic Escherichia coli in Southern Xinjiang: current status and antimicrobial resistance characteristics. Folia Microbiol (Praha). 2026. https://pubmed.ncbi.nlm.nih.gov/42090104/

[20] Yongyod R, Eiamsam-Ang T, Kamolrat N, et al. Fluoroquinolone-Resistant Avian Pathogenic Escherichia coli Isolated from Asymptomatic Broiler Chickens in a Slaughterhouse in Northern Thailand. Pathogens. 2026. https://pubmed.ncbi.nlm.nih.gov/41901706/

[21] Fangfang L, Lianhua N, Haiyang W, et al. An IgM monoclonal antibody targeting diguanylate cyclase DgcE potentiates gentamicin activity against avian pathogenic Escherichia coli through modulation of c-di-GMP signaling. BMC Vet Res. 2026. https://pubmed.ncbi.nlm.nih.gov/42226053/

[22] Lu Q, Zhang Z, Zhang Z, et al. From Virulence to Therapy: T6SS-Derived Antimicrobial Peptides A7 Combats APEC and MRSA Infections. Int J Mol Sci. 2026. https://pubmed.ncbi.nlm.nih.gov/41977454/

[23] Dhaouadi S, Khamessi O, Dassi RB, et al. Leveraging the antibacterial and antibiofilm activities of Cymbopogon flexuosus essential oil against multidrug-resistant bacteria recovered from avian colibacillosis and bovine mastitis: in vitro and molecular docking insights. Vet Res Commun. 2026. https://pubmed.ncbi.nlm.nih.gov/42240774/

[24] Ezzat A, Salem HM, Mahmoud SH, et al. Comprehensive evaluation of Balanites aegyptiaca extracts: in vitro bioactivities and in vivo antimicrobial efficacy and hematological impact on broiler chickens challenged with E. coli O78 and Clostridium perfringens type A. Vet Res Commun. 2026. https://pubmed.ncbi.nlm.nih.gov/41945174/

[25] Thapa K, Phan A, Tung CW, et al. Evaluation of Probiotic Metabolites Mediated Antimicrobial Activity and Inhibition of Virulence Factors in Avian Pathogenic Escherichia coli. Probiotics Antimicrob Proteins. 2026. https://pubmed.ncbi.nlm.nih.gov/42020674/

[26] Wani BM, Kamil SA, Shah SA, et al. Comparative evaluation of outer membrane protein and whole cell antigen vaccine against avian pathogen Escherichia coli infection in broiler chicken. Iran J Microbiol. 2026. https://pubmed.ncbi.nlm.nih.gov/42112298/

[27] Scuotto A, Ogonczyk-Makowska D, Magnez R, et al. Safety, Immunogenicity, and Vaccine Compatibility of a Trivalent Inactivated In Ovo Nanovaccine Against Avian Colibacillosis in Broilers Under Commercial Hatchery Conditions. Animals (Basel). 2026. https://pubmed.ncbi.nlm.nih.gov/41897908/